Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages

Ítems similars

• Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
  per: Lemaire, Sandrine, et al.
  Publicat: (2010)
• Comparative Intracellular (THP-1 Macrophage) and Extracellular Activities of β-Lactams, Azithromycin, Gentamicin, and Fluoroquinolones against Listeria monocytogenes at Clinically Relevant Concentrations
  per: Carryn, Stéphane, et al.
  Publicat: (2002)
• Mechanism of the Intracellular Killing and Modulation of Antibiotic Susceptibility of Listeria monocytogenes in THP-1 Macrophages Activated by Gamma Interferon
  per: Ouadrhiri, Youssef, et al.
  Publicat: (1999)
• Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
  per: Llano-Sotelo, Beatriz, et al.
  Publicat: (2010)
• Pharmacodynamic Evaluation of the Intracellular Activity of Antibiotics towards Pseudomonas aeruginosa PAO1 in a Model of THP-1 Human Monocytes
  per: Buyck, Julien M., et al.
  Publicat: (2013)